Nanocrystalline eye drop, preparation method and use thereof
AssigneeChengdu Ruimu Pharmaceuticals Co., Ltd.
InventorQing DONG
Life of this patent
Estimating the term…
Abstract
A nanocrystalline eye drop contains a double-soluble macromolecule, a single-soluble macromolecule, and a fat-soluble drug. The double-soluble macromolecule and the single-soluble macromolecule interact with each other to encapsulate the fat-soluble drug to form and stabilize a nanocrystalline. The drug can rapidly pass through a blood-ocular barrier into a vitreous body by means of special intercellular space infiltration and/or pinocytosis, and achieve an effective therapeutic effect by means of passive targeting and attachment.
Claims14
A nanocrystalline eye drop, characterized by comprising a double-soluble macromolecule, a single-soluble macromolecule and a fat-soluble drug;
- the double-soluble macromolecule and the single-soluble macromolecule interact with each other to encapsulate the fat-soluble drug to form and stabilize a nanocrystalline.
Dependencies are inferred from the claim text.